Powerful antioxidant acat inhibitors exhibit in vitro anti-inflammatory properties (original) (raw)
ACAT Inhibition Reduces the Progression of Preexisting, Advanced Atherosclerotic Mouse Lesions Without Plaque or Systemic Toxicity
Ilda Bander
Arteriosclerosis, Thrombosis, and Vascular Biology, 2013
View PDFchevron_right
Effect of ACAT inhibition on the progression of coronary atherosclerosis
Paul Schoenhagen
… England Journal of …, 2006
View PDFchevron_right
ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia
Raphaël Duivenvoorden, Evan Stein
JAMA, 2009
View PDFchevron_right
ACAT inhibitors: evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents
Bruce Roth
Drug Discovery Today, 1998
View PDFchevron_right
Anti-cytokine therapy for prevention of atherosclerosis
Dragana Nikolic
Phytomedicine, 2016
View PDFchevron_right
Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions
P. Lallier, Réda Ibrahim
Circulation, 2004
View PDFchevron_right
Pharmacological modulation of vascular inflammation in atherothrombosis
Egeria Scoditti
Annals of the New York Academy of Sciences, 2010
View PDFchevron_right
Atherosclerosis and Current Anti-Oxidant Strategies for Atheroprotection
Gaia Favero
Current Trends in Atherogenesis, 2013
View PDFchevron_right
Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines
Anastasia Poznyak
International Journal of Molecular Sciences
View PDFchevron_right
The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis
Rafał Olszanecki
Medical Science Monitor, 2012
View PDFchevron_right
Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial
P. Lallier, Réda Ibrahim
Atherosclerosis, 2008
View PDFchevron_right
Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways
Che-ming Teng
Journal of Biomedical Science, 2011
View PDFchevron_right
Inflammation as a Therapeutic Target in Atherosclerosis
Mau Nguyen
Journal of Clinical Medicine, 2019
View PDFchevron_right
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Göran Hansson
European Heart Journal, 2009
View PDFchevron_right
Anti-inflammatory therapy for cardiovascular disease
Peter D. Montan Y.
Annals of Translational Medicine, 2019
View PDFchevron_right
Inflammation in Atherosclerosis: New Opportunities for Drug Discovery
Mini-Reviews in Medicinal Chemistry MRMC
Bentham Science Publishers
View PDFchevron_right
Update on the role of acyl-CoA:cholesterol acyltransferase inhibitors in atherosclerosis
Rajiv Doshi
Expert Opinion on Therapeutic Patents, 2001
View PDFchevron_right
Acrolein‐induced atherogenesis by stimulation of hepatic flavin containing monooxygenase 3 and a protection from hydroxytyrosol
Falak Zeb
Journal of Cellular Physiology, 2018
View PDFchevron_right
Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall
Amir Guri
The Journal of Nutritional Biochemistry, 2010
View PDFchevron_right
Atropa acuminata Royle Ex Lindl. blunts production of pro-inflammatory mediators eicosanoids., leukotrienes, cytokines in vitro and in vivo models of acute inflammatory responses
Albeena Nisar
Journal of Ethnopharmacology, 2013
View PDFchevron_right
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis
Stanislav Kotlyarov
International Journal of Molecular Sciences
View PDFchevron_right
Intensive Treatment With Atorvastatin Reduces Inflammation In Mononuclear Cells and Human Atherosclerotic Lesions In One Month
Luis Ortega
Stroke, 2005
View PDFchevron_right
Pharmacological basis of the use of Acorus calamus L. in inflammatory diseases and underlying signal transduction pathways
SAIMA GUL
Latin American and Caribbean Bulletin of Medicinal and Aromatic Plants, 2014
View PDFchevron_right
Role of AntiOxidants in Atherosclerosis: Epidemiological and Clinical Update
Giovanni B. Vigna
Current Pharmaceutical Design, 2005
View PDFchevron_right
ACAT as a Drug Target for Alzheimer’s Disease
Henri Huttunen
Neurodegenerative Diseases, 2008
View PDFchevron_right
Inflammation in Atherosclerosis: Some Thoughts About Acute Coronary Syndromes
Carl Pepine
Circulation, 2006
View PDFchevron_right
Inflammation in atherosclerosis
soraya taleb
Archives of Cardiovascular Diseases, 2016
View PDFchevron_right
The quest for immunotherapy in atherosclerosis: CANTOS study, interleukin-1β and vascular inflammation
valmore bermudez
Journal of thoracic disease, 2018
View PDFchevron_right
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis
Rafał Olszanecki
British Journal of Pharmacology, 2017
View PDFchevron_right
The Role of Inflammation in Atherosclerosis: A Comprehensive Review of Mechanisms and Therapeutic Targets
omar elsaka
Journal of Indian College of Cardiology, 2024
View PDFchevron_right
Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis
maha rashid
Journal of Physiology and Biochemistry, 2011
View PDFchevron_right
Clinical Advances in Immunonutrition and Atherosclerosis: A Review
Rosa Casas
Frontiers in Immunology, 2019
View PDFchevron_right